- Home
- NOTV vs PGZ Comparison
NOTV vs PGZ Comparison
Compare NOTV & PGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- PGZ
- Stock Information
- Founded
- NOTV 1974
- PGZ 2012
- Country
- NOTV United States
- PGZ United States
- Employees
- NOTV N/A
- PGZ N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- PGZ Investment Managers
- Sector
- NOTV Health Care
- PGZ Finance
- Exchange
- NOTV Nasdaq
- PGZ Nasdaq
- Market Cap
- NOTV 62.5M
- PGZ 70.2M
- IPO Year
- NOTV 1997
- PGZ N/A
- Fundamental
- Price
- NOTV $2.08
- PGZ $10.46
- Analyst Decision
- NOTV Strong Buy
- PGZ
- Analyst Count
- NOTV 1
- PGZ 0
- Target Price
- NOTV $5.00
- PGZ N/A
- AVG Volume (30 Days)
- NOTV 385.1K
- PGZ 23.0K
- Earning Date
- NOTV 08-06-2025
- PGZ 01-01-0001
- Dividend Yield
- NOTV N/A
- PGZ 12.26%
- EPS Growth
- NOTV N/A
- PGZ N/A
- EPS
- NOTV N/A
- PGZ N/A
- Revenue
- NOTV $480,402,000.00
- PGZ N/A
- Revenue This Year
- NOTV $4.99
- PGZ N/A
- Revenue Next Year
- NOTV $5.39
- PGZ N/A
- P/E Ratio
- NOTV N/A
- PGZ N/A
- Revenue Growth
- NOTV N/A
- PGZ N/A
- 52 Week Low
- NOTV $1.15
- PGZ $8.46
- 52 Week High
- NOTV $6.48
- PGZ $10.59
- Technical
- Relative Strength Index (RSI)
- NOTV 50.54
- PGZ 54.61
- Support Level
- NOTV $1.86
- PGZ $10.27
- Resistance Level
- NOTV $2.15
- PGZ $10.50
- Average True Range (ATR)
- NOTV 0.20
- PGZ 0.09
- MACD
- NOTV 0.01
- PGZ -0.00
- Stochastic Oscillator
- NOTV 49.31
- PGZ 88.46
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About PGZ Principal Real Estate Income Fund of Beneficial Interest
Principal Real Estate Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to provide high current income with capital appreciation by investing in commercial real estate-related securities. The company does its investments in USA, Australia, Japan, France, Great Britain, Canada, Hong Kong, Germany, Singapore, South Korea, British Virgin Islands and more.